Integrated Ophthalmology and Medical Optics Platform

Rare opportunity. We have an exceptionally attractive sell‑side mandate in the medical optics and ophthalmology sector. It is an integrated platform with 3 locations, an asset‑light model, no debt, generating 1,,050,000 USD EBITDA with a 64% operating margin. Investment Highlights: -Exceptional financial performance EBITDA: 1,050K USD, 64% margin Sustained organic growth: 14% CAGR EBITDA‑to‑cash conversion: >90% Solvency and Financial Risk: Zero debt, 0% financial risk -Full vertical integration: ophthalmology, medical optics, and in‑house laboratory -Mature brand with 25 years of history and an excellent market reputation -Standardized operational processes, easy to scale into additional locations -Under‑penetrated market with significant potential for regional expansion The deal has been vetted by the banks and has been through one round of Due Diligence already. If interested, contact me directly for NDA and more information. Best, Lucian